DEUTSCHE BANK AG\ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,594,098
-31.4%
110,599
-36.6%
0.00%0.0%
Q2 2023$8,149,739
-59.0%
174,550
-66.4%
0.00%
-63.6%
Q1 2023$19,878,940
-15.2%
519,575
+21.5%
0.01%
-15.4%
Q4 2022$23,437,028
+5312.7%
427,683
+3260.7%
0.01%
Q3 2022$433,000
+211.5%
12,726
-13.8%
0.00%
Q2 2022$139,000
-40.6%
14,763
-10.7%
0.00%
Q1 2022$234,000
-39.1%
16,531
-9.0%
0.00%
Q4 2021$384,000
-53.5%
18,171
-50.8%
0.00%
Q3 2021$826,000
-12.5%
36,967
-2.8%
0.00%
Q2 2021$944,000
+8.0%
38,045
+26.3%
0.00%
Q1 2021$874,000
-48.7%
30,129
-54.4%
0.00%
-100.0%
Q4 2020$1,704,000
-53.9%
66,055
-45.0%
0.00%
-66.7%
Q3 2020$3,695,000
+161.5%
119,991
+111.6%
0.00%
+200.0%
Q2 2020$1,413,000
+2378.9%
56,714
+1996.6%
0.00%
Q1 2020$57,000
+54.1%
2,705
+60.0%
0.00%
Q4 2019$37,000
+27.6%
1,691
+28.4%
0.00%
Q3 2019$29,0001,3170.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders